Hint mode is switched on Switch off
For swift navigation between sections

Haemato
LEI 529900Q3CGRYVCW7E340

Organization name
Haemato AG
Country name
Germany
Country of registration
Germany
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

HAEAMTO is a pharmaceutical company aiming to reduce the cost within the German healthcare system. Our company stands to provide pharmaceuticals for the care of chronically ill people. Since 2005 pharmacists and patients have been receiving high quality generics as well as parallel and reimports from HAEMATO. HAEMATO is an established and listed company employing more than 150 employees in its headquarters situated in Schoenefeld, Brandenburg. Our continuing success has been down to the competence and unique skills of our employees.

Awards

Documentation

Stocks

Public debt by currencies

Codes

  • LEI
    529900Q3CGRYVCW7E340
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
Registration is required to get access.